Z-1897-2013 Class I Terminated
FDA device recall Z-1897-2013 was initiated by Nova Biomedical Corporation on Jul 15, 2013 and is designated Class I. Reason for recall: Reports of false abnormally high glucose readings from test strips The recall status is terminated (terminated Aug 1, 2017). Affected quantity: 22,395,802 test strips.
Recall details
- Product Type
- Devices
- Report Date
- Aug 21, 2013
- Initiation Date
- Jul 15, 2013
- Termination Date
- Aug 1, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 22,395,802 test strips
Product description
Reason for recall
Distribution pattern
Worldwide Distribution - USA Nationwide and the countries of Chile, England , Peru, Nicaragua
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1897-2013
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Nova Biomedical Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.